Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tolerance assays: measuring the unknown.

Kenneth A Newell1, Christian P Larsen

  • 1The Emory Transplant Center and Department of Surgery, Emory University, Atlanta, Georgia 30345, USA. kenneth_newell@emoryhealthcare.org

Transplantation
|June 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing a core outcome measure for cancer in trials in kidney transplantation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Because "it's tough to make predictions especially about the future," we should ensure all living donors have access to the best postdonation care.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Advancing Hope Through Science: The Inaugural Richard Slayman International Workshop on Xenotransplantation.

Transplantation·2026
Same author

Adjuvant IL-15 Blockade Significantly Improves Survival in a CD28-based Immunosuppression Protocol of Pig-to-nonhuman Primate Renal Xenotransplantation.

Transplantation·2026
Same author

Critically Important Cancer Outcomes to Report in Kidney Transplant Trials.

Kidney international reports·2025
Same author

Development of a Flexible Multiplex Urine RNA Assay for Detection and Differentiation of Kidney Allograft Injury.

medRxiv : the preprint server for health sciences·2025
Same journal

Filtered or Fried? Rethinking Intraoperative Cell Salvage in Liver Transplantation.

Transplantation·2026
Same journal

Simultaneous Liver-kidney Versus Liver Transplantation Categorized by Pretransplant eGFR: Impact of the 2017 OPTN Policy.

Transplantation·2026
Same journal

Preformed Anti-DQ Alpha Donor-specific Antibodies and the Risk of Antibody-mediated Rejection After Kidney Transplantation.

Transplantation·2026
Same journal

People in Transplantation: Professor Nadey Hakim, MD, PhD, FRCS, FRCSGlas (Hon), FACS, President-Elect of The Transplantation Society.

Transplantation·2026
Same journal

IL-1 Receptor Blockade Modulates Inflammation During Sequential Perfusion in Ex Vivo Porcine Kidneys.

Transplantation·2026
Same journal

Regulatory T Cells Allosensitized Under the Blockade of CD80/CD86-CD28 Costimulation Prolonged Islet Allograft Survival.

Transplantation·2026
See all related articles

Identifying transplant recipients who can safely reduce immunosuppression requires reliable immune monitoring. This review discusses promising assays for detecting donor-specific tolerance, crucial for developing safer transplant regimens.

Area of Science:

  • Transplantation immunology
  • Immunosuppression management
  • Immune tolerance monitoring

Background:

  • Distinguishing transplant recipients needing reduced immunosuppression from those requiring lifelong therapy is a major clinical challenge.
  • Current immune monitoring assays lack the accuracy to predict donor-specific tolerance in human transplant recipients.
  • Developing strategies for immune monitoring is essential for personalized immunosuppression management.

Purpose of the Study:

  • To review and discuss potential assays for identifying transplant recipients who have achieved donor-specific tolerance.
  • To highlight the critical need for validating these tolerance assays for clinical application.
  • To inform the development of safer, less intensive immunosuppression regimens.

Main Methods:

Related Experiment Videos

  • Review of existing and emerging immune monitoring assays relevant to transplantation.
  • Discussion of the potential utility of various assays in predicting or confirming donor-specific tolerance.
  • Analysis of the requirements for assay validation in human subjects.

Main Results:

  • Several immune monitoring assays show promise for identifying tolerant transplant recipients.
  • No single assay currently provides definitive prediction of donor-specific tolerance in humans.
  • Validation is paramount before these assays can guide clinical decisions.

Conclusions:

  • Accurate immune monitoring is key to reducing or withdrawing immunosuppression in select transplant recipients.
  • Further validation of tolerance-specific assays is critical for advancing personalized immunosuppression strategies.
  • Successful development of tolerance regimens hinges on reliable immune monitoring tools.